Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportInstrumentation & Data Analysis Track

Comparison of pharmacokinetic parameters in dynamic 18F-FET PET of glioma

Lena Vomacka, Nathalie Albert, Erik Mille, Bogdana Suchorska, Marcus Unterrainer, Peter Bartenstein and Guido Boening
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 370;
Lena Vomacka
2Dept. of Nuclear Medicine Ludwig-Maximilians University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie Albert
2Dept. of Nuclear Medicine Ludwig-Maximilians University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Mille
2Dept. of Nuclear Medicine Ludwig-Maximilians University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bogdana Suchorska
1Dept. of Neurosurgery Ludwig-Maximilians University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Unterrainer
2Dept. of Nuclear Medicine Ludwig-Maximilians University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Bartenstein
2Dept. of Nuclear Medicine Ludwig-Maximilians University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guido Boening
2Dept. of Nuclear Medicine Ludwig-Maximilians University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

370

Objectives Glioma grading with dynamic 18F-FET PET is typically performed by qualitative analysis of tumoral 18F-FET uptake over time (increasing vs. decreasing shape of time-activity curves). The aim of this work was to investigate quantitative parameters derived from pharmacokinetic and pseudo-kinetic models for the differentiation of WHO grade 2, 3 and 4 glioma in dynamic 18F-FET PET (0-40 min p.i.).

Methods For each of the 39 patients with glioma (WHO2: 11; WHO3: 17; WHO4: 11) one blood volume-of-interest (VOI; 55% isocontour) and one tumor VOI (SUV &gt 1.8 x background) were segmented. Furthermore, within each tumor VOI, sub-VOIs including voxels with similar time-to-peak (TTP) were defined. Kinetic parameters for the entire tumor VOI and the TTP-dependent sub-VOIs were derived from Patlak-plot, RE-plot, 2- and 3-compartment models (2CM, 3CM), and a linear fit to the late frames (15-40 min).

Results The resulting parameters obtained for the entire tumor VOIs are summarized in the two tables. The differentiation between low grade (WHO grade 2) and high grade (WHO grade 3 and 4) glioma (p &lt 0.01) was successful with TTP, SUV at TTP, linear fit (slope and intercept), Patlak-plot (VT), RE-plot (VT and intercept), 2CM (K1 and k2), and 3CM (k4, K1/k2 and k3/k4). No significant differences were found for the remaining parameters. None of the parameters allowed for the differentiation of grade 3 and 4 glioma (p &gt 0.1). The analysis of each tumor’s TTP-dependent sub-VOIs showed that approx. 53% of the voxels of each high grade tumor volume had a maximum activity between 10 and 20 min p.i. (3CM: K1/k2=0.6, k3/k4=1.6), whereas only 15% of the voxels exhibited a peak activity after 30 min. p.i. (3CM: K1/k2=0.7, k3/k4=3.7). In the low grade glioma, 55% of the voxels presented their maximum activity later than 30 min. p.i. (3CM: K1/k2=0.4, k3/k4=3.3). However 38% of the voxels in low grade glioma revealed a peak between 15 and 30 min. p.i. (3CM: K1/k2=0.4, k3/k4=2.7).

Conclusions We found significant differences between high and low grade gliomas for various kinetic parameters. Notably, areas with early peak uptake could be detected with a voxel-based analysis within histologically proven WHO grade 2 gliomas, supporting the identification of tumor heterogeneities. In combination with other parameters, e.g. a high uptake rate, this observation might raise suspicion for the presence of aggressive sub-areas. Whether this may have an impact on clinical procedures and patient’s prognosis has to be further investigated in future studies.

View this table:
  • View inline
  • View popup

Kinetic parameters in dynamic 18FET PET of WHO grade 2, 3 and 4 glioma (part 1)

View this table:
  • View inline
  • View popup

Kinetic parameters in dynamic 18FET PET of WHO grade 2, 3 and 4 glioma (part 2)

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of pharmacokinetic parameters in dynamic 18F-FET PET of glioma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of pharmacokinetic parameters in dynamic 18F-FET PET of glioma
Lena Vomacka, Nathalie Albert, Erik Mille, Bogdana Suchorska, Marcus Unterrainer, Peter Bartenstein, Guido Boening
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 370;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of pharmacokinetic parameters in dynamic 18F-FET PET of glioma
Lena Vomacka, Nathalie Albert, Erik Mille, Bogdana Suchorska, Marcus Unterrainer, Peter Bartenstein, Guido Boening
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 370;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Instrumentation & Data Analysis Track

  • Deep Learning Based Kidney Segmentation for Glomerular Filtration Rate Measurement Using Quantitative SPECT/CT
  • The Benefit of Time-of-Flight in Digital Photon Counting PET Imaging: Physics and Clinical Evaluation
  • Preclinical validation of a single-scan rest/stress imaging technique for 13NH3 cardiac perfusion studies
Show more Instrumentation & Data Analysis Track

Instrumentation & Data Analysis: Data Analysis & Management: Quantification and Kinetic Modeling in Oncology

  • Assessment of cellular proliferation in recurrent primary brain cancer with 3'-deoxy-3'-18F-fluorothymidine PET imaging.
  • Accuracy and precision of parametric analysis of dynamic [18F]FLT PET in NSCLC patients.
Show more Instrumentation & Data Analysis: Data Analysis & Management: Quantification and Kinetic Modeling in Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire